Careview Communications and TruBridge Compared

Which medical technology company is the better investment?

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Careview Communications (OTCMKTS:CRVW) and TruBridge (NASDAQ:TBRG) are both medical technology companies, but which one is the better investment? This article compares the two companies based on factors like profitability, dividends, institutional ownership, risk, valuation, earnings, and analyst recommendations.

Why it matters

Investors looking to gain exposure to the medical technology sector may be weighing the merits of Careview Communications and TruBridge as potential investment options. Understanding how these two companies compare across key financial and operational metrics can help inform investment decisions.

The details

TruBridge has stronger institutional ownership at 88.6% compared to Careview Communications' 63.9% insider ownership. TruBridge also has a lower beta of 0.64, indicating it is less volatile than the overall market. In terms of valuation, Careview Communications has lower revenue but higher earnings per share than TruBridge. TruBridge has higher net margins, return on equity, and return on assets.

  • The analysis is based on data as of February 20, 2026.

The players

TruBridge, Inc.

A provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Careview Communications, Inc.

A provider of video monitoring solutions in the United States, including products for patient safety, resident monitoring, and telehealth applications.

Got photos? Submit your photos here. ›

The takeaway

Investors evaluating Careview Communications and TruBridge should consider factors like financial performance, risk profile, and competitive positioning to determine which medical technology company may be the better long-term investment.